DK0502032T3 - Midler med forsinket frigivelse - Google Patents

Midler med forsinket frigivelse

Info

Publication number
DK0502032T3
DK0502032T3 DK90917183.7T DK90917183T DK0502032T3 DK 0502032 T3 DK0502032 T3 DK 0502032T3 DK 90917183 T DK90917183 T DK 90917183T DK 0502032 T3 DK0502032 T3 DK 0502032T3
Authority
DK
Denmark
Prior art keywords
pct
delayed release
sec
release agents
date
Prior art date
Application number
DK90917183.7T
Other languages
Danish (da)
English (en)
Inventor
Stephen Gordon Ring
David Brian Archer
Michael Charles Allwood
John Michael Newton
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Application granted granted Critical
Publication of DK0502032T3 publication Critical patent/DK0502032T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
DK90917183.7T 1989-11-24 1990-11-22 Midler med forsinket frigivelse DK0502032T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898926639A GB8926639D0 (en) 1989-11-24 1989-11-24 Delayed release formulations

Publications (1)

Publication Number Publication Date
DK0502032T3 true DK0502032T3 (da) 1994-05-09

Family

ID=10666886

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90917183.7T DK0502032T3 (da) 1989-11-24 1990-11-22 Midler med forsinket frigivelse

Country Status (17)

Country Link
US (1) US5294448A (fr)
EP (1) EP0502032B1 (fr)
JP (1) JP2975680B2 (fr)
KR (1) KR920703030A (fr)
AT (1) ATE103174T1 (fr)
CA (1) CA2069485C (fr)
DE (1) DE69007623T2 (fr)
DK (1) DK0502032T3 (fr)
ES (1) ES2053206T3 (fr)
FI (1) FI103091B1 (fr)
GB (2) GB8926639D0 (fr)
HU (1) HU209243B (fr)
NO (1) NO303424B1 (fr)
NZ (1) NZ236188A (fr)
RU (1) RU2093148C1 (fr)
WO (1) WO1991007949A1 (fr)
ZA (1) ZA909384B (fr)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3034592B2 (ja) * 1990-11-20 2000-04-17 わかもと製薬株式会社 経口用固形製剤及びその製造法
DE4120918A1 (de) * 1991-06-25 1993-01-07 Basf Ag Pulverfoermige praeparate aus einer wasserunloeslichen kernsubstanz und einer schutzhuelle
US6764697B1 (en) * 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
DE69229710T2 (de) * 1991-11-15 2000-03-02 Kanegafuchi Chemical Ind Esterbindung enthaltende Polymere für pharmazeutische Zubereitungen
US7070806B2 (en) 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
EP0621032B1 (fr) * 1993-04-23 2000-08-09 Novartis AG Dispositif d'administration de médicaments à libération contrôlée
US5514663A (en) * 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
US5565407A (en) * 1993-12-27 1996-10-15 University Of Kansas Center For Research, Inc. Biologically active agent encapsulated in biodegradable starch/polymer matrices
US6166024A (en) 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
US5656294A (en) * 1995-06-07 1997-08-12 Cibus Pharmaceutical, Inc. Colonic delivery of drugs
GB9516268D0 (en) 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon
SK282669B6 (sk) * 1995-12-21 2002-11-06 Farmaceutisk Laboratorium Ferring A/S Prostriedok na orálne podanie s modifikovaným uvoľňovaním účinnej látky na liečbu zápalových črevných ochorení
US6004581A (en) * 1995-12-21 1999-12-21 Farmaceutisk Laboratorium Ferring A/S Modified release oral pharmaceutical composition and method for the treatment of bowel diseases
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
US6231888B1 (en) 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
US5891474A (en) 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
GB9722426D0 (en) * 1997-10-23 1997-12-24 Univ London Pharmacy Controlled release formulations
GB9724186D0 (en) * 1997-11-14 1998-01-14 British Tech Group Low temperature coatings
WO2001078626A1 (fr) * 2000-04-13 2001-10-25 Sts Biopolymers, Inc. Dispositifs de liberation ciblee d'agents therapeutiques et procedes de fabrication et de mise en oeuvre de tels dispositifs
CA2359812C (fr) 2000-11-20 2004-02-10 The Procter & Gamble Company Formes posologiques pharmaceutiques a couches multiples permettant de reduire l'impact des revetement fractures
FI20002768A (fi) * 2000-12-18 2002-06-19 Licentia Oy Enteropäällysteisiä lääkekoostumuksia ja niiden valmistus
MXPA03008293A (es) * 2001-03-13 2003-12-11 Penwest Pharmaceuticals Co Formas de dosis cronoterapeuticas.
US7771468B2 (en) * 2001-03-16 2010-08-10 Angiotech Biocoatings Corp. Medicated stent having multi-layer polymer coating
US20070098784A1 (en) 2001-09-28 2007-05-03 Nutraceutix, Inc. Delivery system for biological component
GB0203421D0 (en) * 2002-02-13 2002-04-03 Alizyme Therapeutics Ltd Composition
US20050118267A1 (en) * 2003-09-19 2005-06-02 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms
JP2007505921A (ja) * 2003-09-19 2007-03-15 ペンウェスト ファーマシューティカルズ カンパニー 遅延放出剤形
WO2005065291A2 (fr) * 2003-12-31 2005-07-21 Genzyme Corporation Agents sequestrants des acides biliaires a base de polymeres d'amine aliphatique a revetement gastro-resistant
ES2323536T3 (es) * 2004-09-01 2009-07-20 The Procter And Gamble Company Composiciones que comprenden acido-5-amino-2-hidroxibenzoico yh un azucar reductor.
US20060165745A1 (en) * 2005-01-21 2006-07-27 Yiwen Chew Sustained release tablets for treatment of aqueous environment and methods for making the same
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
GB0607534D0 (en) * 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
JP2010523555A (ja) 2007-04-04 2010-07-15 シグモイド・ファーマ・リミテッド 「経口医薬組成物」
TWI422398B (zh) * 2007-06-04 2014-01-11 Univ London 結腸給藥配方
GB0714030D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
GB0714029D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
NZ592049A (en) 2008-10-03 2012-11-30 Falk Pharma Gmbh Compositions and methods for the treatment of bowel diseases with granulated mesalamine
ES2425762T3 (es) * 2008-10-27 2013-10-17 Roquette Freres Polímero insoluble en agua: revestimientos de película a base de derivados de almidón modificado para la liberación dirigida al colon
CA2749278A1 (fr) 2009-01-14 2010-07-22 Novacta Biosystems Limited Derives de deoxyactagardine
CN102388060B (zh) 2009-02-04 2014-09-10 诺瓦克塔生物系统有限公司 阿肽加定衍生物
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
EP2386297A1 (fr) * 2010-04-28 2011-11-16 Roquette Frères Non digérable polymère : Revêtements basé sur d'acetate d'amidon pour cibler le colon
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
BR112013010157B1 (pt) 2010-11-08 2020-02-04 Albireo Ab iinibidores do ibat, seus usos, e composição e combinações farmacêuticas
AU2013240289B2 (en) 2012-03-29 2018-01-25 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
LT2659881T (lt) 2012-04-30 2018-02-12 Tillotts Pharma Ag Uždelsto atpalaidavimo vaisto forma
JP6464142B2 (ja) 2013-03-14 2019-02-06 セラバイオーム，エルエルシー プロバイオティクス生物及び／又は治療剤の標的化胃腸管デリバリー
EP3542791A1 (fr) 2013-10-29 2019-09-25 Tillotts Pharma AG Formulation de médicament à libération retardée
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
CA2952406A1 (fr) 2014-06-25 2015-12-30 Ea Pharma Co., Ltd. Preparation solide et procede d'inhibition ou d'attenuation de coloration de celle-ci
AU2015341695B2 (en) 2014-11-07 2021-07-08 Sublimity Therapeutics Limited Compositions comprising cyclosporin
DE102015000795A1 (de) * 2015-01-23 2016-07-28 Se Tylose Gmbh & Co. Kg Reversibel vernetzte Celluloseether und Verfahren zu deren Herstellung durch selektive Oxidation von vicinalen OH-Gruppen
US10441604B2 (en) 2016-02-09 2019-10-15 Albireo Ab Cholestyramine pellets and methods for preparation thereof
US10786529B2 (en) * 2016-02-09 2020-09-29 Albireo Ab Oral cholestyramine formulation and use thereof
US10441605B2 (en) 2016-02-09 2019-10-15 Albireo Ab Oral cholestyramine formulation and use thereof
JP2020530448A (ja) 2017-08-09 2020-10-22 アルビレオ・アクチボラグ コレスチラミン顆粒、経口コレスチラミン製剤、及びそれらの使用
US10793534B2 (en) 2018-06-05 2020-10-06 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
MX2020013839A (es) 2018-06-20 2021-03-25 Albireo Ab Formulacion farmaceutica de odevixibat.
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
EP3662898A1 (fr) 2018-12-07 2020-06-10 Tillotts Pharma AG Formulation solide comprenant de la mésalamine
EP3662901A1 (fr) 2018-12-07 2020-06-10 Tillotts Pharma AG Formulation de medicaments a liberation ranlentie avec une couche exterieure comprenant un polymere degradable par des enzymes, sa composition et son processus de production
EP3662900A1 (fr) 2018-12-07 2020-06-10 Tillotts Pharma AG Formulation d'administration de médicament colonique
EP3662902A1 (fr) 2018-12-07 2020-06-10 Tillotts Pharma AG Formulation pour la liberation de médicaments dans le côlon

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3360633D1 (en) * 1982-02-12 1985-10-03 Unitika Ltd Anti-cancer device
US4755397A (en) * 1986-12-24 1988-07-05 National Starch And Chemical Corporation Starch based particulate encapsulation process
US4911952A (en) * 1987-07-10 1990-03-27 The United States Of America As Represented By The Secretary Of Agriculture Encapsulation by entrapment within matrix of unmodified starch
GB8812490D0 (en) * 1988-05-26 1988-06-29 Agricultural & Food Res Delayed release formulations

Also Published As

Publication number Publication date
GB9025373D0 (en) 1991-01-09
GB2238243B (en) 1993-09-08
KR920703030A (ko) 1992-12-17
EP0502032A1 (fr) 1992-09-09
EP0502032B1 (fr) 1994-03-23
ATE103174T1 (de) 1994-04-15
FI103091B (fi) 1999-04-30
GB8926639D0 (en) 1990-01-17
FI922369A (fi) 1992-05-22
RU2093148C1 (ru) 1997-10-20
HUT62463A (en) 1993-05-28
JP2975680B2 (ja) 1999-11-10
DE69007623T2 (de) 1994-06-30
WO1991007949A1 (fr) 1991-06-13
HU209243B (en) 1994-04-28
ES2053206T3 (es) 1994-07-16
HU9201719D0 (en) 1992-08-28
ZA909384B (en) 1992-07-29
FI103091B1 (fi) 1999-04-30
CA2069485C (fr) 2000-04-18
DE69007623D1 (de) 1994-04-28
NO922026L (no) 1992-07-23
NZ236188A (en) 1992-11-25
GB2238243A (en) 1991-05-29
US5294448A (en) 1994-03-15
FI922369A0 (fi) 1992-05-22
JPH05504947A (ja) 1993-07-29
NO303424B1 (no) 1998-07-13
NO922026D0 (no) 1992-05-22

Similar Documents

Publication Publication Date Title
DK0502032T3 (da) Midler med forsinket frigivelse
BR9611175B1 (pt) compostos e composiÇÕes farmacÊuticas.
ATE75936T1 (de) Zusammensetzungen mit verzoegerten wirkstoffabgaben.
FI955979A0 (fi) Jatkuvasti vapauttava, kalvopäällysteinen astemitsoli- ja pseudoefedriinitabletti
ATE154237T1 (de) Inhalationspulver enthaltend antistatisches hilfsmittel
DK0741757T3 (da) Biologisk nedbrydelige 3-polyhydroxybutyrat-/3-polyhydroxyhexanoatcopolymerfilm
MY112915A (en) Multiple unit tableted dosage form 1
IL124674A0 (en) Piperazine derivatives pharmaceutical compositions containing the same and use thereof
DE69333023D1 (de) 3-beta-hydroxylierte natürliche Steroidderivate enthaltende Arzneimittelzusammensetzungen und ihre Verwendung
ATE167690T1 (de) Polyetheramidoamine hydrogele als heparinersatz
DK0749304T3 (da) Retardtablet med et indhold af diclofenac-Na
ATE207480T1 (de) Substituierte aminoalkylaminopyridine
HU9401458D0 (en) Leukotriene-b4 derivatives, process for preparing the same and medicaments